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Abstract: In the ovary, the luteinizing hormone (LH) surge suppresses the proliferation and
induces the luteinization of preovulatory granulosa cells (GCs), which is crucial for the survival of
terminally-differentiated GCs. Krüppel-like factor 4 (Klf4) has been shown to play a role in regulating
the cell cycle and apoptosis in various cell types. The rapid induction of Klf4 expressions by LH was
observed in preovulatory GCs. To evaluate whetherKlf4 affects GC proliferation and survival, primary
rat GCs were isolated from pregnant mare serum gonadotropin-primed Sprague–Dawley rat ovaries
and transfected with a Klf4 expression vector or Klf4-specific siRNA, followed by determination of
the transcript levels of apoptosis-related and cell cycle-related genes. Cell proliferation, viability,
and apoptosis were analyzed by BrdU incorporation, a Cell Counting Kit-8 assay, a bioluminescence
caspase 3/7 assay, and flow cytometry. LH treatment increased Klf4 mRNA expression in preovulatory
GCs. Transcripts of B-cell lymphoma 2 (Bcl-2) and cell cycle promoters (Cyclin D1 and Cyclin D2)
decreased, whereas those of the cell cycle inhibitor, p21, increased. Altering the expression of
Klf4 by overexpression or knockdown consistently affected the expression of Bcl-2 and Cyclin D1.
In agreement with this, Klf4 overexpression reduced cell viability, increased the fraction of apoptotic
cells, and arrested cell cycle progression in G1 phase. We conclude that Klf4 increases the susceptibility
of preovulatory GCs to apoptosis by down-regulating Bcl-2, and promotes LH-induced cell cycle
exit. It appears to be a key regulator induced by the LH surge that determines the fate of GCs in
preovulatory follicles during the luteal transition.
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1. Introduction
Whether the follicles are growing or atretic depends on the balance between anti-apoptotic and
pro-apoptotic factors that determine the rate of granulosa cell (GC) apoptosis. Although apoptosis
can occur at any stage of follicular development, follicles that are more differentiated are more prone
to apoptosis than early-stage follicles [1]. In addition, the factors regulating follicular cell survival
before and after the luteinizing hormone (LH) surge appear to differ. In response to the LH surge,
the expression of diverse genes is rapidly and dramatically changed in preovulatory follicles [2].
For instance, highly expressed genes in growing preovulatory follicles are turned off by the LH surge,
whereas various different genes that are relevant to luteinization increase dramatically during the
periovulatory period [3].
The Krüppel-like factor family of transcription factors plays important roles in many biological
processes, including proliferation, apoptosis, and differentiation [4,5]. Krüppel-like factor 4 (Klf4)
expression was first reported in the epithelial lining of the gut and skin, and its effect on cell cycle
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arrest and apoptosis is different depending on the cellular context [6–8]. An LH-induced up-regulation
of Klf4 expression in porcine GCs in vitro has been reported [9], and it is involved in apoptosis in
several mammalian cell types [10]. Since luteinizing GCs cease to multiply, it is conceivable that Klf4 is
induced by LH and influences the cell cycle transition and apoptosis of periovulatory GCs during this
critical period. However, there is no direct evidence for anti-apoptotic or pro-apoptotic actions of Klf4,
or its effects on cell cycle arrest, and its role in the ovary is largely unknown.
In this study, we investigated whether Klf4 is regulated by LH and whether it is involved in cell
cycle arrest and the loss of cell viability during the luteal transition period in rat preovulatory GCs
in vitro. Cell cycle arrest was analyzed by measuring the induction of cell cycle-related genes such as
Cyclin D1, D2, p21, and p27 along with an analysis of 5-bromo-2′deoxyuridine (BrdU) incorporation
and flow cytometry. Cell viability was analyzed by examining the expression of apoptosis-regulating
genes, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X (Bax) [11], accompanied by a cell counting kit-8
assay (CCK-8), a sensitive bioluminescence caspase 3/7 assay, and flow cytometry analysis. Here,
we found that Klf4 increases the susceptibility of preovulatory GCs to apoptosis by down-regulating
Bcl-2, and promotes LH-induced cell cycle exit.
2. Results
2.1. LH Regulates the Expression of Klf4, Bcl-2, and Cell Cycle Genes in Preovulatory GCs
To investigate changes in the expression of Klf4 and the genes regulating apoptosis and the cell
cycle in preovulatory GCs in the early phase of LH exposure, cells were cultured in the presence of
LH (0, 100, 200 ng/mL) for 45 min, and real-time PCR analysis was performed (Figure 1). The culture
time of 45 min was based on preliminary measurements of Klf4 expression after LH exposure for
15 min to 24 h. As shown in Figure 1A, LH treatment led to dose-dependent increases in Klf4 mRNA.
For example an ovulatory dose of LH of 200 ng/mL led to a 6.6-fold increase in the Klf4 mRNA level
compared to untreated control cells. LH treatment reduced the expression of Bcl-2 and the Bcl-2/Bax
ratio in a dose-dependent manner, whereas no clear changes were found in the Bax transcript levels
compared to the control (Figure 1B). LH treatment decreased the expression of cell cycle promoters
(cyclin D1 and D2), and increased that of p21 at 200 ng/mL (Figure 1C).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW  3  of  13 
 
 
Figure 1. Effect of luteinizing hormone  (LH) on Krüppel‐like  factor 4  (Klf4), transcripts of apoptosis‐ 
and  cell  cycle‐related  genes  in  cultured  preovulatory  granulosa  cells  (GCs).  Real‐time  RT‐PCR 
analysis  of  transcripts  of  (A)  Klf4;  (B)  Bax,  and  Bcl‐2;  and  (C)  Cyclins D1,  D2,  p21,  and  p27  in 
preovulatory GCs  in response  to LH  (0 ng/mL, 100 ng/mL, and 200 ng/mL). All of  the expression 
levels were  normalized  to  18S  rRNA  levels.  Values were  calculated  as  fold  changes  relative  to 




GCs  from  pregnant mare  serum  gonadotropin  (PMSG)‐primed  rat  ovaries were  transfected 
with a Klf4 expression vector or Klf4‐specific small interfering RNA (siRNA). The overexpression or 
knockdown  of  Klf4  in GCs was  confirmed  by  real‐time  reverse  transcription  polymerase  chain 
reaction  (RT‐PCR) and Western blotting analysis  (Supplementary Figure S1). Klf4 overexpression 
caused  significant  decreases  in  Bcl‐2  transcripts, which were  accompanied  by  reduced  Bcl‐2/Bax 
ratios, with no effect on Bax expression  itself  (Figure 2A). Conversely, Klf4 knockdown  increased 
Bcl‐2 mRNA  expression  and  the Bcl‐2/Bax  ratio  (Figure  2C). Klf4 overexpression down‐regulated 
cyclins D1 and D2, and up‐regulated the cell cycle inhibitor p21 (Figure 2B), whereas only cyclin D2 
was  significantly  up‐regulated  in  response  to  Klf4  inhibition  (Figure  2D),  suggesting  that  Klf4 
blocked cell cycle progression primarily by down‐regulating cyclin D2.   
Figure 1. Cont.
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Figure 1. Effect of luteinizing hormone (LH) on Krüppel-like factor 4 (Klf4), transcri ts of apoptosis- and
cell cycle-related genes in cultured preovulatory granulosa cells (GCs). Real-time RT-PCR analysis of
transcripts of (A) Klf4; (B) Bax, and Bcl-2; and (C) Cyclins D1, D2, p21, and p27 in preovulatory GCs in
response to LH (0 ng/mL, 100 ng/mL, and 200 ng/mL). All of the expression levels were normalized to
18S rRNA levels. Values were calculated as fold changes relative to untreated cells and are expressed as
means ± standard deviations (SDs) of three separate experiments. LH, luteinizing hormone. * p < 0.05,
vs. untreated cells; † p < 0.05, vs. cells treated with 100 ng/mL of LH.
2.2. Effect of Klf4 on Expression of Apoptosis-Related and Cell Cycle-Related Genes in Preovulatory GCs
GCs from pregnant mare serum gonadotropin (PMSG)-primed rat ovaries were transfected
with a Klf4 expression vector or Klf4-specific mall interfering RNA (siRNA). The ov rexpr ssion
or knockdown of Klf4 in GCs was confirmed by real-time reverse transcription polymerase chain
reaction (RT-PCR) and Western blotting analysis (Supplementary Figure S1). Klf4 overexpression
caused significant decreases in Bcl-2 transcripts, which were accompanied by reduced Bcl-2/Bax
ratios, with no effect on Bax expression itself (Figure 2A). Conversely, Klf4 knockdown increased Bcl-2
mRNA expression and the Bcl-2/Bax ratio (Figure 2C). Klf4 overexpression down-regulated cyclins
D1 and D2, and up-regulated the ell cycle inhibitor p21 (Figure 2B), whereas only cyclin D2 w s
significantly up-regulated in respons to Klf4 inhibition (Figure 2D), suggesting that Klf4 blocked cell
cycle progression primarily by down-regulating cyclin D2.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW  4  of  13 
 
 
Figure  2.  Regulation  of  apoptosis‐related  and  cell  cycle‐related  genes  expression  by  Klf4  in 









Flag‐Klf4 or  empty vector  (CT)  and  cultured  for 24 h without  serum  to avoid  any  effects on  the 
growth factors in serum. FSH was used as a positive control [12]. The overexpression of Klf4 in the 
GCs was confirmed by real‐time PCR (Supplementary Figure S1C). The CCK‐8 assay was used to 
monitor  the  effect of Klf4 on GC viability. Klf4 overexpression decreased CCK‐8  activity by  30% 
compared to the control (p = 0.035 vs. CT) (Figure 3A). Since the CCK‐8 assay measures the metabolic 
activity of  living cells and does not assess cell death, cell viability was measured by  trypan blue 
exclusion.  The  percentage  of  viable  cells  fell  by  approximately  14%  in Klf4‐overexpressing  cells 
(from 80.3 ± 6.4% to 66 ± 3.3%) (Figure 3B). We also analyzed apoptosis quantitatively by measuring 
caspase 3/7 activity. Transfected GCs were  cultured with or without  serum or  follicle‐stimulating 
hormone (FSH). The enzymatic activities that were measured in each group were compared with the 
activities  in  the  control  cells. As  shown  in Figure 3C,  in  the GCs  cultured with 10%  fetal bovine 
serum  (FBS)  and  FSH,  caspase 3/7 activity was 0.7‐fold  and  0.8‐fold of  the activity  in  the  control, 
respectively  (p  <  0.05).  The  overexpression  of Klf4  caused  an  approximately  1.3‐fold  increase  in 
caspase‐3/7 activity compared to the control cells (p = 0.05).   
After FSH treatment, BrdU‐labeled GCs increased twofold relative to non‐treated control cells 
(p  <  0.01),  whereas  they  declined  to  half  the  control  level  of  10.1  ±  1.1%  among  the 
Klf4‐overexpressing  cells  (4.8  ±  1.7%)  (p  <  0.01)  (Figure  3D).  These  results  indicate  that  Klf4  is 
implicated in the regulation of cell survival and proliferation in preovulatory GCs.   
Figure 2. Cont.
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Figure 2. Regulation of apoptosis-related and cell cycle-related genes expression by Klf4 in preovulatory
GCs. (A,C) Real-time RT-PCR analysis of Bax and Bcl-2 mRNA levels in GCs transfected with Klf4
expression vector (300 ng) and Klf4-specific siRNA (200 nM); (B,D) Real-time RT-PCR analysis of cyclins
D1, D2, p21 and p27 mRNA levels in GCs transfected with Klf4 expression vector and Klf4-specific
siRNA. 18S rRNA was used to normalize each reaction. Values are calculated as fold changes relative to
empty vector (CT) or non-target siRNA (NT), and are expressed as the means ± SDs of three separate
experiments. CT, cells transfected with empty vector; NT, cells transfected with non-target siRNA.
* p < 0.05, ** p < 0.01 vs. CT or NT.
2.3. Klf4 Overexpression Reduces Cell Viability and Proliferation of GCs
To determine the effects of Klf4 on GC viability and proliferation, cells were transfected with
Flag-Klf4 or empty vector (CT) and cultured for 24 h without serum to avoid any effects on the
growth factors in serum. FSH was used as a positive control [12]. The overexpression of Klf4 in
the GCs was confirmed by real-time PCR (Supplementary Figure S1C). The CCK-8 assay was used
to monitor the effect of Klf4 on GC viability. Klf4 overexpression decreased CCK-8 activity by 30%
compared to the control (p = 0.035 vs. CT) (Figure 3A). Since the CCK-8 assay measures the metabolic
activity of living cells and does not assess cell death, cell viability was measured by trypan blue
exclusion. The percentage of viable cells fell by approximately 14% in Klf4-overexpressing cells
(from 80.3 ± 6.4% to 66 ± 3.3%) (Figure 3B). We also analyzed apoptosis quantitatively by measuring
caspase 3/7 activity. Transfected GCs were cultured with or without serum or follicle-stimulating
hormone (FSH). The enzymatic activities that were measured in each group were compared with
the activities in the control cells. As shown in Figure 3C, in the GCs cultured with 10% fetal bovine
serum (FBS) and FSH, caspase 3/7 activity was 0.7-fold and 0.8-fold of the activity in the control,
respectively (p < 0.05). The overexpression of Klf4 caused an approximately 1.3-fold increase in
caspase-3/7 activity compared to the control cells (p = 0.05).
After FSH treatment, BrdU-labeled GCs increased twofold relative to non-treated control cells
(p < 0.01), whereas they declined to half the control level of 10.1 ± 1.1% among the Klf4-overexpressing
cells (4.8 ± 1.7%) (p < 0.01) (Figure 3D). These results indicate that Klf4 is implicated in the regulation
of cell survival and proliferation in preovulatory GCs.
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Fig re 3. Effects of Klf4 overexpression on cell viability and proliferation of preovulatory GCs.
Cell viability was determined by (A) CCK-8 cell counting assay (ALX-850-039-0100, Enzo) and
(B) trypan blue exclusion in cells transfected with Klf4 expression vector (300 ng/well) or empty
vector (CT, control). * p < 0.05, ** p < 0.0001 vs. CT; (C) Analysis of caspase 3/7 activity. GCs transfected
with Klf4 or empty vector were incubated without seru , and some control cells were treated with fetal
bovine serum (FBS) or follicle-stimulating hormone (FSH) as positive controls for apoptosis suppressors.
Twenty-four h later, caspase 3/7 activity was measured with the bioluminescence assay. FBS, 10% fetal
bovine serum. * p < 0.05 vs. CT; (D) 5-bromo-2′deoxyuridine (BrdU)-incorporation assay. DNA labeling
indices were determined by the scoring number of BrdU(+) nuclei per total nuclei, and are presented
as means ± SDs. ** p < 0.001 vs. CT. Representative fluorescence microscopy images of BrdU-labeled
GCs (100×) (lower panel). Cells were stained with BrdU antibody (B2531, Sigma, 1:200) to visualize
BrdU-labeled cells (pink) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) to confirm
nuclear status (blue). CT, control cells transfected with empty vector; FSH, follicle-stimulating hormone
(50 ng/mL); KLF4, cells transfected with Klf4 (300 ng).
2.4. Klf4 Overexpression Induces Apoptosis and Promotes Cell Cycle Arrest in GCs
As Klf4 overexpression reduced the expression of anti-apoptotic factors and cell growth,
we examined its impact on apoptosis and the cell cycle in GCs. To estimate the pro-apoptotic effect
of Klf4 in GCs, apoptotic cells were measured by Annexin V and 7-aminoacinomycin D (AAD)
staining and the flow cytometry of GCs transfected with Klf4 or an empty vector. The percentage of
apoptotic cells (Annexin V+/AAD−) increased up to 33% in Klf4-transfected cells compared with
empty vector-transfected controls (18%) (Figure 4A). As shown in Figure 4B, Klf4 overexpression also
increased the proportion of G0/G1 phase cells (CT, 73.3 ± 10.4 vs. Klf4, 84.9 ± 10.1%), and reduced
the proportion of S-phase cells compared to the control (CT, 12.7 ± 6.4 vs. Klf4, 5.5 ± 3.2%), although
statistical significance was not attained (vs. CT, p = 0.05). The percentage of cells in the G2/M phase
was comparable in the two groups. These results indicate that Klf4 is involved in the induction of
apoptosis, and cell cycle arrest in G0/G1, in preovulatory GCs.
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Luteinizing GCs  exit  the  cell  cycle and  stop dividing, and  this  is accompanied by  the  rapid 
down‐regulation of the cell cycle gene, cyclin D2, as well as activation of the cell cycle inhibitors, p21 
and p27 [14]. Our results confirmed that ovulatory doses of LH decreased the expression of cyclin D2 
and  increased p21 mRNA  in GCs, with no significant change  in p27 mRNA  (Figure 1C). We also 
observed a decrease in the expression of cyclin D1, which is another cell cycle gene [15].   
Since Klf4 has been known to cause G1/S arrest through the transcriptional activation of p21 or 
p27  and  by  the  direct  inhibition  of  cyclin D1  in  various  types  of  non‐gonadal  cells  [16–20], we 
( ) The flow cytometric detec ion f apoptosis in GCs transfected with empty vector (CT, control)
(left pane ), or Klf4 expression vector (300 ng) (right panel). The cells wer stained with A nexin-V
and 7-aminoacinomycin D (AAD). The percentages indicate th proportions of late apoptotic cells
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cycle distributions were calculated and expressed as means ± SDs of three independent experiments.
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3. Discussion
The transient induction of specific transcription factors in periovulatory follicles by the LH surge
play an important role in cellular division, apoptosis, and differentiation [3]. In this study, we showed
that LH significantly increased Klf4 expression in preovulatory GCs, and that Klf4 inhibited cell growth
and induced apoptosis in these cells, indicating a role for Klf4 as a regulator of cell growth and
apoptosis during the periovulatory period.
Using DNA chip technology, the Klf4 gene has been identified in mice ovarian follicles as one of the
folliculogenesis-related genes [13], and its transcript level was markedly increased in Graafian follicles
compared to preantral follicles [13]. In addition, LH stimulation rapidly increased Klf4 transcripts
within 2 h in porcine granulosa-lutein cells in vitro [9]. Consistent with this, we observed that LH
treatment led to a dose-dependent increase of the Klf4 transcript level in preovulatory GCs (Figure 1A),
suggesting that the ovulatory LH stimulus could be an initial trigger of Klf4 expression.
Luteinizing GCs exit the cell cycle and stop dividing, and this is accompanied by the rapid
down-regulation of the cell cycle gene, cyclin D2, as well as activation of the cell cycle inhibitors, p21
and p27 [14]. Our results confirmed that ovulatory doses of LH decreased the expression of cyclin
D2 and increased p21 mRNA in GCs, with no significant change in p27 mRNA (Figure 1C). We also
observed a decrease in the expression of cyclin D1, which is another cell cycle gene [15].
Since Klf4 has been known to cause G1/S arrest through the transcriptional activation of p21 or
p27 and by the direct inhibition of cyclin D1 in various types of non-gonadal cells [16–20], we analyzed
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the expression of these cycle regulators. In addition, cyclin D2, a potent activator of the cell cycle in the
G1/S phase, was also evaluated because it is selectively expressed in the GCs of growing follicles in
the ovary [14]. As expected, Klf4 overexpression decreased cyclins D1 and D2 transcripts and increased
those of p21 in preovulatory GCs (Figure 2B), and Klf4 knockdown increased cyclin D2 expression
(Figure 2D). However, Klf4 knockdown had no effects on the p21 mRNA expression; considering that
Klf4 expression was not completely blocked by siRNA treatment in the present study (Supplementary
Figure S1-B,D), it is possible that only the complete absence of Klf4 would have an effect on p21
gene expression.
In agreement with the effects in cell cycle regulators, the overexpression of Klf4 inhibited GC
proliferation (Figure 3D) and cell cycle progression at the G1/S transition (Figure 4B). p27 is also
known as a potent inhibitor of cyclin-dependent kinases in the G1 phase of the cell cycle and its mRNA
increases in response to Klf4 overexpression in non-gonadal cells [16–21]. However, changes in Klf4
expression had no effects on p27 mRNA levels in GCs (Figure 2B,D). Since p27 is known to be regulated
primarily at the post-translational level [22,23], its mRNA level may not change after Klf4 induction
in GCs.
We also characterized the LH-induced changes in the expression of the Bcl-2 proto-oncogene
(an inhibitor of apoptosis) and Bax (an inducer of apoptosis), which are involved in GC apoptosis [24].
The observed LH-induced decrease in Bcl-2 expression coupled with constant Bax mRNA levels
(Figure 1B) may be associated with the transient induction of GCs apoptosis before the luteal transition.
Since periovulatory GCs are more prone to apoptosis than immature GCs [25–27], Klf4 may also be
implicated in the increased susceptibility of preovulatory GCs to apoptosis during this transition
period. In fact, evidence from various mammalian cell types indicates that Klf4 induces apoptosis
by regulating the transcription of Bax and Bcl-2 [10], and we also observed that Klf4 overexpression
decreased in Bcl-2 expression without changing Bax mRNA levels, thus lowering the Bcl-2/Bax ratio
(Figure 2A). Another important regulator of the apoptotic process is the caspase family of proteases [28].
The increased permeability of mitochondria under the influence of Bax results in the activation of
caspases 3 and 7 as the final common pathway of apoptosis [29,30]. In addition to Bcl-2 and Bax
regulation by Klf4 in GCs, we demonstrated the pro-apoptotic effects of Klf4 as shown in Figure 3C,
although these were not statistically significant. Along with this, Klf4 overexpression reduced cell
viability and increased the proportion of apoptotic cells (Figures 3A and 4A). Previous studies also
found that Klf4 overexpression suppressed Bcl-2 expression in mice small follicles and in the GCs
isolated from them [10]. However, they also reported the Klf4-induced activation of Bax expression.
This discrepancy may be due to the differences in cell maturity or sensitivity to apoptosis as a function
of follicle growth. Since Klf4 is highly expressed in Graafian follicles [13] and regulated by LH treatment
in GCs, using preovulatory GCs might be more appropriate for analyzing the effect of Klf4 on GCs
than whole ovaries or small follicles. In ovarian cancer cells, Klf4 overexpression increased Bcl-2
expression, but had no effect on cell viability [31]. Previous studies indicate that Klf4 may switch from
anti-apoptotic to pro-apoptotic depending on the context [32–34]. Thus, Klf4 seems to regulate Bcl-2 or
Bax differently in ovarian cancer cells than in normal ovarian cells due to unidentified cellular factors.
Considering that the massive apoptosis of preovulatory GCs in vitro is suppressed by an ovulatory
dose of LH [35], redundant mechanisms to ensure their survival may exist. Follicle maturation and
ovulation are critically dependent on gonadotropins that work in concert with intraovarian factors to
suppress the cell death program [36]. The signaling pathway and potencies of various survival factors
are different according to the follicle growth [36]. For instance, the activation of the Phosphoinositide
3-kinase/Protein kinase B (PI3K/Akt) pathway by ghrelin is involved in the regulation of cell survival
and anti-apoptotic protection in bovine cumulus cells [37,38].
Collectively, our results suggest that Klf4 may influence the susceptibility of preovulatory GCs to
apoptosis at a number of points, including the regulation of upstream regulator (down-regulating Bcl-2,
thereby decreasing the Bcl-2/Bax ratio) and downstream effectors (caspase 3 and 7). In addition, Klf4
may contribute to the LH-induced cell cycle exit by altering cell cycle regulators at the G1/S checkpoint
Int. J. Mol. Sci. 2019, 20, 87 8 of 13
after the LH surge, and some time before the complete luteal transition. Thus, Klf4 is a transcriptional
regulator influencing the fate of preovulatory GCs by reducing cell growth and increasing apoptosis
during the luteal transition.
4. Materials and Methods
4.1. Animals and Reagents
Immature female Sprague–Dawley rats were obtained from Orient Biokorea (Kyunggi-do,
South Korea) and housed under controlled conditions (22–24 ◦C, humidity 40–50%, 12-h light–dark
cycle), with free access to food and water. Animal care was consistent with institutional guidelines, and
the Hanyang University Animal Care and Use committee approved all of the procedures involving
animals (HY-IACUC-16-0013, approval date: 24 February 2014). McCoy’s 5a medium (modified) and
Leibovitz L-15 medium were obtained from GIBCO (Santa Clara, CA, USA). Penicillin and streptomycin
were obtained from Sigma (St. Louis, MO, USA) and recombinant human FSH (Org 32489E) and ovine
LH (NIH-LH-23) were from NV Organon (Oss, The Netherlands) and the National Hormone and
Pituitary Distribution Program (Baltimore, MD, USA), respectively.
4.2. Preparation and Culture of Preovulatory Granulosa Cells
Animals aged 26 days (body weight 55–60 g) were injected intraperitoneally with 10 International
Unit (IU) of pregnant mare serum gonadotropin (PMSG) (Sigma-Aldrich, St. Louis, MO, USA) to
induce the growth of multiple preovulatory follicles. Forty-eight h later, ovaries were dissected, and
preovulatory follicles were punctured to obtain granulosa cells. Ovarian debris and small follicles
were removed, and GCs were collected by low-speed centrifugation at 500 × g for 10 min, dispersed
by repeated washing and suspended in culture medium (McCoy’s 5a supplemented with two mM
of L-glutamine, 100 U/mL of penicillin, and 100 µg/mL of streptomycin). To evaluate the effect of
LH on expression of Klf4 on apoptosis-related and cell cycle-related genes, cells were plated in a
24-well culture dish (5 × 104 viable cells/well) and cultured in the absence or presence of LH (100 and
200 ng/mL) for 45 min. At the end of the experiment, they were frozen for RNA extraction.
4.3. Plasmid Construction and Transfection
The pCMV3×FLAG-Klf4 (FLAG-Klf4) construct was made by subcloning full-length rat Klf4
cDNA (kindly provided by H. Kook; Chonnam National University Medical School, Gwangju, Korea).
Klf4-specific siRNA (Klf4-siRNA) was synthesized by Genepharma (Shanghai, China); the sequences of
the 25-nucleotide sense and antisense RNAs were: 5′-CCAUUAUCAAGAGCUCAUGCCACCG-3′
(sense) and 5′-CGGUGGCAUGAGCUCUUGAUAAUGG-3′ (antisense) (accession no.: NM_053713).
Non-targeting control siRNA (Universal Scrambled siRNA) was purchased from Genepharma
(Shanghai, China). For transient transfections, GCs were resuspended in electroporation buffer
(MPK1025; Thermo Fisher Scientific, Waltham, MA, USA), mixed with expression vectors or siRNA,
and electroporated with a single pulse of 1000 V, 40 milliseconds, using a Neon™ Transfection System
(MPK5000, Thermo Fisher Scientific, Waltham, MA, USA). This procedure was based on the results of
preliminary optimization experiments that achieved a transfection efficiency of approximately 70%.
The transfected cells (1 × 105 cells/well) were resuspended in culture medium, plated in 24-well
culture plates, collected after 24–36 h, and snap-frozen for the isolation of RNA or proteins.
4.4. Total RNA Extraction and Real-Time Quantitative RT-PCR Analysis
Total RNA was isolated with an RNeasy extraction kit (Qiagen Inc., Valencia, CA, USA). One-µg
aliquots of total RNA were annealed (five min at 70 ◦C) to oligo(dT)18 primers and reverse transcribed
using cDNA synthesis platinum master mix (GenDEPOT, Katy, TX, USA). Primers were designed
for the mRNA sequences of Klf4, Bax, Bcl-2, cyclin D1, cyclin D2, p21, and p27 using the Primers
Express program (PE Applied Biosystems, Foster City, CA, USA) (Table 1). Real-time PCR reactions
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were carried out in total volumes of 20 µL, with Prime Q-Master Mix (with SYBR Green I) (GeNet
Bio Inc., Daejeon, South Korea) using a LightCycler 480 II System (Roche Molecular Diagnostics,
Indianapolis, IN, USA). The PCR cycle conditions were as follows: 10 min at 95 ◦C, 45 cycles of
95 ◦C for 10 s, 58~60 ◦C for 10 s, and 72 ◦C for 10 s. 18S rRNA was amplified and used to normalize
each reaction. Samples were run in triplicate (Roche Molecular Diagnostics, Indianapolis, IN, USA),
and mean values were compared with the control values to calculate relative amounts of transcript.
Data are expressed as means ± standard deviations (SDs) of duplicate or triplicate measurements in
four independent experiments.
Table 1. Primer sequences used for real-time PCR amplification.
Gene Primer Sequence (5′-3′) Product Size (bp) Accession Number







Cyclin D1 F: TCAAGTGTGACCCGGACTG 213 NM_171992.4R: CACTACTTGGTGACTCCCGC










F, forward; R, reverse; p21Cip1, cyclin-dependent kinase-interaction protein 1; p27Kip1, cyclin-dependent kinase
inhibitor 1B.
4.5. Western Blot Analysis
Transfected GCs were lysed in Laemmli buffer containing β-mercaptoethanol (BioRad, Hercules,
CA, USA). Samples were resolved by 8% Sodium dodecyl sulfate-polyacrylamide (SDS-PAGE)
gel electrophoresis, transferred to nitrocellulose membranes (Amersham Pharmacia Biotech,
Arlington Heights, IL, USA), and immunoblotted with anti-KLF4 antibody (4038, Cell Signaling
Tech., Inc., Danvers, MA, USA) diluted 1:200. The membranes were washed and blotted with
peroxidase-conjugated donkey anti-rabbit secondary antibody (1:2000) (Boehringer Mannheim,
Indianapolis, IN, USA). Immunolabeled proteins were detected using an enhanced chemiluminescence
kit (Pierce Chemical Co., Rockford, IL, USA). The 65-kDa KLF4 protein is indicated in Supplementary
Figure S1D. To ensure that the lysates were loaded equally, the blots were stripped and incubated with
an anti-β-actin antibody (1:4000) (Sigma, St. Louis, MO, USA).
4.6. Cell Counting Kit-8 Assays
Cell viability was determined using a CCK-8 (Enzo, Ann Arbor, MI, USA). Dehydrogenase
enzymes present in metabolically active cells convert water-soluble tetrazolium-8 salt (WST-8)
[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium
salt] to a water-soluble formazan dye. The amount of the formazan dye that is generated is proportional
to the number of living cells. GCs transfected with empty vector (EV) or Flag-Klf4 (300 ng/well) were
plated in 96-well plates (1 × 104 cells/well) and cultured in McCoy 5a medium containing 1% fetal
bovine serum (FBS). Sixteen to 24 h after transfection, WST-8 solution was added and incubation
continued in serum-free medium for 2 h. The quantity of formazan product was measured at 450 nm
with an ELISA plate reader (BioRad, Hercules, CA, USA). The experiment was repeated three times,
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and the data are expressed as fold changes relative to the control values measured with empty
vector-transfected cells. Cell viability was evaluated using trypan blue staining [39]. Equal volumes
of 0.4% trypan blue were added to cell suspensions, and viable (unstained) and dead (stained) cells
were counted using a hemocytometer. The data are expressed as percentages of viable cells. All of the
experiments were replicated at least three times to assure reproducibility (Louis, MO, USA).
4.7. Caspase 3/7 Assays
Apoptosis was also assessed with the caspase 3/7 activity assay using a luminescence assay kit
(Caspase-Glo 3/7 assay; Promega, Madison, WI, USA). GCs were cultured in McCoy 5a serum-free
medium with or without FSH or 10% FBS for 24 h after transfection. Then, proluminescent Caspase-Glo
3/7 reagent was added to each well, and the cells were gently mixed and incubated at room temperature
for one h. Luminescence was measured on a Monolight 2010 luminometer (Analytical Luminescence
Laboratory, San Diego, CA, USA). The data were expressed as fold changes relative to the empty vector
transfected cell (control). All of the experiments were replicated three times.
4.8. 5-Bromo-2′-Deoxyuridine (BrdU) Incorporation
Cells were plated onto 1.2 × 1.2 cm coverslips in 24-well plates (1 × 105 cells/well). After 16–24 h,
5-bromo-2′-deoxyuridine (BrdU, 3 µg/mL) (B5002, Sigma, St. Louis, MO, USA) was added and
incubation continued for three h, followed by fixation with methanol for 10 min at −20 ◦C and three
washes with phosphate-buffered saline (PBS). The slides were dehydrated, pretreated with 2N HCl at
37 ◦C for 15 min, washed twice with 0.2% Triton X in PBS (pH 7.4), and incubated with 1% normal
goat serum/PBS for one h at room temperature, followed by anti-BrdU antibody (B2531, Sigma,
St. Louis, MO, USA) diluted 1:250 in 1% normal goat serum at 4 ◦C overnight. The slides were
then washed with PBS and incubated with 1:200 goat anti-mouse Alexa Fluor 488® IgG (Thermo
Fisher Scientific, Waltham, MA, USA) for one h at 37 ◦C, and nuclear DNA was counterstained
with 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc., Burlingame, CA, USA). Five
magnified fields (100×) were randomly selected, and the number of BrdU-positive cells per field was
counted under a fluorescence microscopy (Leica, Heidelberg, Germany). The proliferation rate (%)
was defined as the percentage of total cells that were BrdU-positive.
4.9. Flow Cytometric Analysis
For assessing apoptosis, cells were washed twice with cold PBS, resuspended in 1X binding buffer
(1 × 106 cells) (BD Biosciences, San Jose, CA, USA) and stained with APC-Annexin V and 7-AAD
(BD Biosciences, San Jose, CA, USA) for 15 min in the dark at room temperature. Unstained cells were
used to set negative gates, and each cell that was stained with either Allophycocyanin (APC)-Annexin
V or 7-Aminoactinomycin D (7-AAD) alone was used to set the compensation parameters. Apoptosis
rates were measured using a flow cytometer (FACSCalibur, BD Biosciences, San Jose, CA, USA) and
analyzed with Cell Quest software (BD Biosciences, San Jose, CA, USA).
For cell cycle analysis, cells (1 × 106 cells) were harvested, fixed in 70% (v/v) ethanol for two h
at −20 ◦C, washed twice with PBS, treated with RNase A (iNtRON Biotechnology, Seoul, Korea),
and stained with propidium iodide (Sigma, St. Louis, MO, USA) at room temperature for 30 min in the
dark. Using flow cytometry, the proportion of cells in each phases (G0-G1, S, and G-M) were analyzed.
4.10. Statistical Analysis
All of the results were expressed as means ± SDs of experiments and repeated at least three times.
All of the data were analyzed using IBM SPSS statistics 21 for Windows (SPSS Inc., Chicago, IL, USA).
Statistical significance was determined by the Mann–Whitney U test for two-group comparisons, and
Kruskal–Wallis one-way analysis of variance for multiple comparisons. Significance was accepted
at p < 0.05.
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5. Conclusions
We conclude that Klf4 increases the susceptibility of preovulatory GCs to apoptosis by
down-regulating Bcl-2 and promotes LH-induced cell cycle exit. It appears to be a key regulator
induced by the LH surge that determines the fate of GCs in preovulatory follicles during the
luteal transition.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/1/
87/s1.
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